Treatment with sodium-glucose cotransporter-2 (SGLT2) inhibitors may have pleiotropic and
beneficial effects in terms of ameliorating of risk factors for the progression of autosomal …

Background: Fluorine-18 fluorodeoxyglucose positron emission tomography/computed
tomography ([18F] FDG PET/CT) has been suggested as a useful imaging method for …

Presently, only personal or family history of intracranial aneurysm/subarachnoid
hemorrhage (IA/SAH) has been established as a risk factor for IA in autosomal dominant …

Background Recently, the importance of attribute-based medicine has been emphasized.
The effects of early-onset intracranial aneurysms on patients can be significant and long …

Polycystic kidney disease is the most prevalent hereditary kidney disease globally and is
mainly linked to the overexpression of a gene called PKD1. To date, there is no effective …

Tolvaptan, an oral vasopressin V2 receptor antagonist, reduces renal volume expansion
and loss of renal function in patients with autosomal dominant polycystic kidney disease …

Background Autosomal dominant polycystic kidney disease (ADPKD) and autosomal
recessive polycystic kidney disease (ARPKD) are major genetic polycystic kidney diseases …

Background Screening for intracranial aneurysms (IAs) in patients with risk factors of IA is
recommended. However, genetic risk factors of IA in patients with autosomal dominant …

Abstract Autosomal Dominant Polycystic Kidney Disease is characterized by renal cyst
development, often leading to kidney enlargement and failure. We conducted whole exome …

Background Acute kidney injury (AKI) diagnosis often lacks a baseline serum creatinine (Cr)
value. Our study aimed to create a regression equation linking kidney morphology to …